{
    "2020-08-22": [
        [
            {
                "time": "2023-10-01",
                "original_text": "It's important that the government invests in vaccines: Dr. Dan Barouch",
                "features": {
                    "keywords": [
                        "government",
                        "invests",
                        "vaccines",
                        "Dr. Dan Barouch"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Novartis immuno-oncology drug candidate fails skin cancer trial",
                "features": {
                    "keywords": [
                        "Novartis",
                        "immuno-oncology",
                        "drug",
                        "fails",
                        "skin cancer",
                        "trial"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Novartis provides update on Phase III study evaluating investigational spartalizumab (PDR001) in combination with Tafinlar速 + Mekinist速 in advanced melanoma",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Phase III",
                        "spartalizumab",
                        "PDR001",
                        "Tafinlar速",
                        "Mekinist速",
                        "advanced melanoma"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}